Follow the people · Insider
Veronica Sanchez Bulis
Veronica Sanchez Bulis files insider transactions with the SEC as a vp, corporate controller of Lyell Immunopharma (LYEL). We hold 5 disclosed purchases and sales filed since 12 November 2025, 2 of them in the last 90 days.
- Files forLYEL
- Disclosed buys and sells5 in all, 2 in the last 90 days
- Last disclosure11 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 November 2025 — 10 August 2026VP, Corporate Controller · Lyell Immunopharma (LYEL)11 Form 4 lines · source: SEC Form 4
Everything they disclosed
11 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 621 shares of Lyell ImmunopharmaSEC Form 411 August 2026Common Stock · traded 10 August 2026 · filed 11 August 2026
- ▼ sold on the open market 217 shares of Lyell ImmunopharmaSEC Form 415 June 2026Common Stock · traded 11 May 2026 · filed 15 June 2026
- was granted 8,750 shares of Lyell ImmunopharmaSEC Form 411 February 2026Common Stock · traded 10 February 2026 · filed 11 February 2026
- ▼ sold on the open market 254 shares of Lyell ImmunopharmaSEC Form 411 February 2026Common Stock · traded 10 February 2026 · filed 11 February 2026
- was granted 8,750 shares of Lyell ImmunopharmaSEC Form 411 February 2026Common Stock · traded 10 February 2026 · filed 11 February 2026
- ▼ sold on the open market 254 shares of Lyell ImmunopharmaSEC Form 411 February 2026Common Stock · traded 10 February 2026 · filed 11 February 2026
- ▼ sold on the open market 1,136 shares of Lyell ImmunopharmaSEC Form 46 January 2026Common Stock · traded 24 December 2025 · filed 6 January 2026
- ▼ sold on the open market 936 shares of Lyell ImmunopharmaSEC Form 46 January 2026Common Stock · traded 30 December 2025 · filed 6 January 2026
- ▼ sold on the open market 1,136 shares of Lyell ImmunopharmaSEC Form 46 January 2026Common Stock · traded 24 December 2025 · filed 6 January 2026
- ▼ sold on the open market 936 shares of Lyell ImmunopharmaSEC Form 46 January 2026Common Stock · traded 30 December 2025 · filed 6 January 2026
- ▼ sold on the open market 239 shares of Lyell ImmunopharmaSEC Form 412 November 2025Common Stock · traded 10 November 2025 · filed 12 November 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.